)
)
Advancing Beyond The Genome: AstraZeneca’s Approach to Delivering Tailored Treatments for Chronic Diseases
- Multi-omics advances understanding of disease mechanisms and delivers biomarker
- Genomic data is critical for causal inference and discovery of therapeutic targets
- Integration of multi-omics data in biobanks and RCTs accelerates clinical translation
- OpenScience: democratising access to big data increases scientific impact
Speakers
